Nopropiophenone en es it fr

Nopropiophenone Brand names, Nopropiophenone Analogs

Nopropiophenone Brand Names Mixture

  • No information avaliable

Nopropiophenone Chemical_Formula


Nopropiophenone RX_link

Nopropiophenone fda sheet

Nopropiophenone FDA

Nopropiophenone msds (material safety sheet)

Nopropiophenone MSDS

Nopropiophenone Synthesis Reference

No information avaliable

Nopropiophenone Molecular Weight

205.296 g/mol

Nopropiophenone Melting Point

No information avaliable

Nopropiophenone H2O Solubility

No information avaliable

Nopropiophenone State

No information avaliable

Nopropiophenone LogP


Nopropiophenone Dosage Forms

25 mg tablets and 75 mg controlled-release tablets.

Nopropiophenone Indication

Used in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.

Nopropiophenone Pharmacology

Diethylpropion is a sympathomimetic stimulant drug marketed as an appetite suppressant. Chemically, it is the N,N-diethyl analog of cathinone. Its mechanism of action is similar to other appetite suppressants such as sibutramine, phentermine and dextroamphetamine.

Nopropiophenone Absorption

Diethylpropion is rapidly absorbed from the GI tract after oral administration.

Nopropiophenone side effects and Toxicity

The reported oral LD50 for mice is 600 mg/kg, for rats is 250 mg/kg and for dogs is 225 mg/kg. Manifestation of acute overdosage include restlessness, tremor, hyperreflexia, rapid respiration, confusion, assaultiveness, hallucinations, and panic states.

Nopropiophenone Patient Information

No information avaliable

Nopropiophenone Organisms Affected

Humans and other mammals